Shinpoong Pharmaceutical Co.,Ltd (KRX:019170)
South Korea
· Delayed Price · Currency is KRW 11,910
+130 (1.10%)
Apr 29, 2026, 3:30 PM KST
KRX:019170 Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 616,702 | 738,559 | 539,247 | 707,263 | 1,124,818 | 1,653,859 | Upgrade
|
| Market Cap Growth | 61.45% | 36.96% | -23.76% | -37.12% | -31.99% | -73.97% | Upgrade
|
| Enterprise Value | 601,805 | 728,856 | 521,260 | 679,012 | 1,050,665 | 1,521,791 | Upgrade
|
| Last Close Price | 11910.00 | 14040.00 | 10310.00 | 13520.00 | 21150.00 | 31950.00 | Upgrade
|
| PE Ratio | 69.24 | 83.69 | - | - | - | - | Upgrade
|
| PS Ratio | 2.63 | 3.15 | 2.44 | 3.53 | 5.38 | 8.74 | Upgrade
|
| PB Ratio | 2.28 | 2.73 | 2.09 | 2.61 | 3.40 | 4.59 | Upgrade
|
| P/TBV Ratio | 2.33 | 2.79 | 2.14 | 2.68 | 3.49 | 4.72 | Upgrade
|
| P/FCF Ratio | 44.77 | 53.61 | - | - | - | - | Upgrade
|
| P/OCF Ratio | 35.74 | 42.81 | - | - | - | - | Upgrade
|
| EV/Sales Ratio | 2.56 | 3.11 | 2.36 | 3.39 | 5.02 | 8.04 | Upgrade
|
| EV/EBITDA Ratio | 23.46 | 28.42 | - | - | - | - | Upgrade
|
| EV/EBIT Ratio | 42.22 | 51.13 | - | - | - | - | Upgrade
|
| EV/FCF Ratio | 43.68 | 52.91 | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.21 | 0.21 | 0.21 | 0.17 | 0.01 | 0.00 | Upgrade
|
| Debt / EBITDA Ratio | 2.18 | 2.18 | - | - | - | - | Upgrade
|
| Debt / FCF Ratio | 4.05 | 4.05 | - | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.06 | -0.06 | -0.01 | -0.05 | -0.16 | -0.25 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.61 | -0.61 | 0.37 | 0.41 | 2.55 | 56.11 | Upgrade
|
| Net Debt / FCF Ratio | -1.14 | -1.14 | 0.09 | 0.36 | 1.70 | 1.21 | Upgrade
|
| Asset Turnover | 0.68 | 0.68 | 0.64 | 0.56 | 0.55 | 0.43 | Upgrade
|
| Inventory Turnover | 2.32 | 2.32 | 2.55 | 2.38 | 2.78 | 2.31 | Upgrade
|
| Quick Ratio | 2.17 | 2.17 | 1.70 | 1.86 | 5.39 | 6.39 | Upgrade
|
| Current Ratio | 3.09 | 3.09 | 2.50 | 2.60 | 7.24 | 8.16 | Upgrade
|
| Return on Equity (ROE) | 3.17% | 3.17% | -5.81% | -19.04% | -10.22% | -3.11% | Upgrade
|
| Return on Assets (ROA) | 2.57% | 2.57% | -3.08% | -8.33% | -5.60% | -2.01% | Upgrade
|
| Return on Invested Capital (ROIC) | 5.56% | 5.54% | -6.64% | -17.78% | -12.47% | -6.22% | Upgrade
|
| Return on Capital Employed (ROCE) | 5.00% | 5.00% | -6.40% | -17.30% | -10.20% | -3.90% | Upgrade
|
| Earnings Yield | 1.43% | 1.20% | -2.85% | -8.11% | -3.15% | -0.70% | Upgrade
|
| FCF Yield | 2.23% | 1.86% | -3.84% | -5.61% | -2.82% | -4.56% | Upgrade
|
| Buyback Yield / Dilution | -0.37% | -0.37% | 0.28% | - | - | -1.85% | Upgrade
|
| Total Shareholder Return | -0.37% | -0.37% | 0.28% | - | - | -1.85% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.